Gene linked to rare disorder also regulates key enzyme in Alzheimer’s
A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.
List view / Grid view
Enzymes are macromolecular biological catalysts. Enzymes accelerate, or catalyse, chemical reactions.
A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.
A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
A new study has revealed that M. tuberculosis uses a unique type of antacid which gives immune cells indigestion, enabling the bacteria to survive.
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
A new study may provide the basis for combating malignant leukemia stem cells.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
A research team have developed a new CRISPR platform called RESCUE (RNA Editing for Specific C to U Exchange).
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
A study has shown that deactivating an enzyme linked to ceramides caused obese mice to improve their metabolic health, indicating a drug target.
A study has discovered that a biomarker associated with pancreatitis is involved in its development to pancreatic cancer.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
Researchers have found an enzyme and its counterpart which inhibit T-cells from attacking tumour cells.
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.